Literature DB >> 16443052

Clinical and serological characteristics of progressive facial hemiatrophy: a case series of 12 patients.

Anna Sommer1, Thilo Gambichler, Martina Bacharach-Buhles, Thomas von Rothenburg, Peter Altmeyer, Alexander Kreuter.   

Abstract

BACKGROUND: Progressive facial hemiatrophy (PFH) is characterized by a slowly progressive atrophy of soft tissues and in some cases bony structures. Coexisting features of localized scleroderma (LS) are commonly observed, indicating the close nature of both disorders.
OBJECTIVE: We sought to investigate clinical, serological, and radiographic findings in PFH from 278 patients with LS and to discuss the relationship to linear scleroderma en coup de sabre (LSCS).
METHOD: A total of 12 patients with PFH were retrospectively evaluated on the basis of clinical, serological, and radiographic findings.
RESULTS: Five patients (42%) presented with complete PFH, and 7 patients (58%) with partial PFH involving either cheek or forehead. Five of the patients (42%) had a coexisting LSCS lesion, and 3 of them (25%) had concomitant LS of the trunk. Intraoral involvement was present in 6 cases. Neurological involvement was common, in particular, epileptic seizures. Serologic investigations showed neither evidence for infection with Borrelia burgdorferi nor any other indication of underlying systemic immunological disorders. LIMITATIONS: There were a relatively small number of patients in a retrospective study.
CONCLUSION: The reported cases suggest a close relationship between PFH and LSCS. PFH might appear as two different subtypes, one involving cutaneous structures and presenting with clinical features similar to LSCS, one being strictly restricted to subcutaneous structures, primarily affecting the cheek area. The manifold clinical features of central nervous system involvement indicate the pathogenetic importance of neurological involvement in the development of PFH. Magnetic resonance imaging should be included in the tools of standard diagnostic procedures in patients with PFH. The etiologic relevance of autoimmunity as well as preceding trauma should be investigated in larger collective studies.

Entities:  

Mesh:

Year:  2006        PMID: 16443052     DOI: 10.1016/j.jaad.2005.10.020

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  28 in total

1.  [Hemiatrophia faciei progressiva (Parry-Romberg-syndrome) ].

Authors:  E Roller; J Reifenberger; B Homey; D Bruch-Gerharz
Journal:  Hautarzt       Date:  2006-10       Impact factor: 0.751

Review 2.  Bioinspired Collagen Scaffolds in Cranial Bone Regeneration: From Bedside to Bench.

Authors:  Justine C Lee; Elizabeth J Volpicelli
Journal:  Adv Healthc Mater       Date:  2017-06-06       Impact factor: 9.933

Review 3.  Parry Romberg Syndrome: 7 Cases and Literature Review.

Authors:  M Wong; C D Phillips; M Hagiwara; D R Shatzkes
Journal:  AJNR Am J Neuroradiol       Date:  2015-06-11       Impact factor: 3.825

4.  Borrelia burgdorferi Infections in the United States.

Authors:  Warren R Heymann; Dana L Ellis
Journal:  J Clin Aesthet Dermatol       Date:  2012-08

5.  Methotrexate and corticosteroids in the treatment of localized scleroderma: a standardized prospective longitudinal single-center study.

Authors:  Kathryn S Torok; Thaschawee Arkachaisri
Journal:  J Rheumatol       Date:  2012-01-15       Impact factor: 4.666

Review 6.  The central nervous system manifestations of localized craniofacial scleroderma: a study of 10 cases and literature review.

Authors:  Ezekiel Maloney; Sarah J Menashe; Ramesh S Iyer; Sarah Ringold; Amit K Chakraborty; Gisele E Ishak
Journal:  Pediatr Radiol       Date:  2018-07-03

7.  Scleroderma linearis: hemiatrophia faciei progressiva (Parry-Romberg syndrom) without any changes in CNS and linear scleroderma "en coup de sabre" with CNS tumor.

Authors:  Beata Bergler-Czop; Anna Lis-Swiety; Ligia Brzezińska-Wcisło
Journal:  BMC Neurol       Date:  2009-07-27       Impact factor: 2.474

8.  Parry-Romberg Syndrome Associated with Localized Scleroderma.

Authors:  Jelena Maletic; Vassiliki Tsirka; Panos Ioannides; Dimitrios Karacostas; Nikolaos Taskos
Journal:  Case Rep Neurol       Date:  2010-06-01

9.  Peripheral blood cytokine and chemokine profiles in juvenile localized scleroderma: T-helper cell-associated cytokine profiles.

Authors:  Kathryn S Torok; Katherine Kurzinski; Christina Kelsey; Jonathan Yabes; Kelsey Magee; Abbe N Vallejo; Thomas Medsger; Carol A Feghali-Bostwick
Journal:  Semin Arthritis Rheum       Date:  2015-06-17       Impact factor: 5.532

10.  A significant proportion of children with morphea en coup de sabre and Parry-Romberg syndrome have neuroimaging findings.

Authors:  Yvonne E Chiu; Sheetal Vora; Eun-Kyung M Kwon; Mohit Maheshwari
Journal:  Pediatr Dermatol       Date:  2012 Nov-Dec       Impact factor: 1.588

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.